Sexually Transmitted Diseases

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2023
DOI
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Autores
Citação
Belda, W. Jr.. Sexually Transmitted Diseases. In: . Dermatology in Public Health Environments: A Comprehensive Textbook, Second Edition: SPRINGER INTERNATIONAL PUBLISHING, 2023. p.159-181.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The majority of sexually transmitted diseases (STDs) have no symptoms or only mild symptoms that may not be recognized as an STD. The most common conditions they cause are gonorrhea, chlamydial infection, syphilis, trichomoniasis, chancroid, genital herpes, genital warts, human immunodeficiency virus (HIV) infection, and hepatitis B infection. Drug resistance is a major threat to reducing the impact of STDs worldwide. When used correctly and consistently, condoms offer one of the most effective methods of protection against STDs, including HIV. Female condoms are effective and safe, but are not used as widely as male condoms by national programs. This chapter presents the main aspects of a major problem for public health. Dermatology can be very important for the management and control of STDs. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.
Palavras-chave
Aids, Chancroid, Chlamydia, Genital, Gonorrhea, Herpes, HIV, HPV, Sexual, STD, STI, Syphilis, Trichomoniasis, Warts
URI
https://observatorio.fm.usp.br/handle/OPI/57185
Referências
  1. Belda W., Doenças Sexualmente Transmissíveis—Classificação, Doenças Sexualmente transmissíveis. 1St Ed, (1999)
  2. Belda W., Doenças Sexualmente Transmissíveis—Conceito e Classificação, Doenças Sexualmente Transmissíveis, (2009)
  3. Belda W., Sífilis adquirida e congênita, Tratado De Dermatologia, (2018)
  4. Paria C.S., Et al., Cell-mediated immunity during syphilis, Br J Vener Dis, 54, pp. 144-150, (1980)
  5. Belda W., Martins H.S., Sífilis adquirida e outras doenças sexualmente transmissíveis, Pronto Socorro- Condutas Do Hospital Das Clinida Faculdade De Medicina Da Universidade De São Paulo, (2006)
  6. Capdevilla J.M., Sífilis. Etiopatogenia, manifestaciones y tratamento, Enfermedades De Transmission Sexual, (1993)
  7. Capdevilla J.M., Bou D., Mascaro J.M., Secundarismo sifilítico. Afectacion ocular, Rev Ibero Latino am ETS, 2, pp. 34-37, (1988)
  8. Souza M.C., Nitrini R., Neurosífilis, Doenças Sexualmente Transmissíveis, (2009)
  9. Belda W., Naud P., Becker E., Flichman J.C., Sífilis, sífilis congenital e diagnostic laboratorial, Doenças Sexualmente Transmissiveis E AIDS, (1993)
  10. Grange P.A., Gressier L., Dion P.L., Et al., Evaluation of a PCR test for detection of Treponema pallidum in swabs and blood, J Clin Microbiol, 50, pp. 546-552, (2012)
  11. Gayet-Ageron A., Sednaoui P., Lautenschlager S., Et al., Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis, Emerg Infect Dis, 21, pp. 127-129, (2015)
  12. Buffet M., Grange P.A., Gerhardt P., Et al., Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry, J Invest Dermatol, 127, pp. 2345-2350, (2007)
  13. Muller H., Eisendle K., Brauninger W., Kutzner H., Cerroni L., Zelger B., Comparative analysis of immuno-histochemistry, polymerase chain reaction and focus-floating microscopy for the detection of Treponema pallidum in mucocutaneous lesions of primary, secondary and tertiary syphilis, Br J Dermatol, 165, pp. 50-60, (2011)
  14. Janier M., Hegyi V., Dupin N., Unemo M., Tiplica G.S., French P., Patel R. 2014 European guideline on the management of syphilis, J Eur Acad Dermatol Venereol, 20, pp. 300-309, (2014)
  15. Nandwani R., Evans D.T.P., Are you sure it’s syphilis? A review of false positive serology, Int J STD AIDS, 6, pp. 241-248, (1995)
  16. Larsen S.A., Steiner B.M., Rudolph A.H., Laboratory diagnosis and interpretation of tests for syphilis, Clin Microbiol Rev, 8, pp. 1-21, (1995)
  17. Geusau A., Kittler H., Hein U., Dangl-Erlach E., Stingl G., Tschachler E., Biological false-positive tests comprise a high proportion of Venereal Disease Research Laboratory reactions in an analysis of 300 000 sera, Int J STD AIDS, 16, pp. 722-726, (2005)
  18. WHO Guidelines for the Treatment of Treponema Pallidum (Syphilis), (2016)
  19. Workowski K.A., Bolan G.A., Sexually transmitted diseases treatment guidelines, 2015, MMWR Recomm Rep, 64, pp. 34-51, (2015)
  20. Wong T., Singh A.E., De P., Primary syphilis treatment response to doxycycline/tetracycline versus benzathine penicillin, Am J Med, 121, pp. 903-908, (2008)
  21. Janier M., Unemo M., Dupin N., Tiplica G.S., Potocnik M., Patel R., European Guideline on the Management of Syphilis, pp. 1-35, (2020)
  22. Santos M.F.Q., Siqueira L.F.G., Belda W., Chancroide. Etiopatogenia, epidemiologia,diagnóstico y tratamento, Enfermedades De Transmission Sexual, (1993)
  23. Fagundes L.J., Cancro Mole, Tratado De Dermatologia, (2018)
  24. Lewis D.A., Chancroid: Clinical manifestations, diagnosis, and management, Sex Transm Infect, 79, pp. 68-71, (2003)
  25. Schmid G.P., Faur Y.C., Valu J.A., Et al., Enhanced recovery of Haemophilus ducreyi from clinical specimens by incubation at 33 versus 35°C, J Clin Microbiol, 33, pp. 3257-3259, (1995)
  26. Sturm A.W., Zanen H.C., Characteristics of Haemophilus ducreyi in culture, J Clin Microbiol, 19, pp. 672-674, (1984)
  27. Orle K.A., Gates C.A., Martin D.H., Et al., Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers, J Clin Microbiol, 34, pp. 49-54, (1996)
  28. Chui L., Maclean I., Marusyk R., Development of the polymerase chain reaction for diagnosis of chancroid, J Clin Microbiol, 31, pp. 659-664, (1993)
  29. West B., Wilson S.M., Changalucha J., Et al., Simplified PCR for detection of Haemophilus ducreyi and diagnosis of chancroid, J Clin Microbiol, 33, pp. 787-790, (1995)
  30. Workowski K.A., Berman S., Sexually transmitted diseases treatment guidelines, 2010, MMWR Recomm, 59, RR-12, pp. 1-10, (2010)
  31. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases), Sex Transm Infect, 75, pp. S43-S45, (1999)
  32. Belda W., Fagundes L.J., Lfg S., Neisseria gonorrhoeae: Resistência cromossômica à tetraciclina em São Paulo, Brasil, An Bras Dematol, 80, 1, pp. 37-40, (2005)
  33. Sexually Transmitted Diseases Treatment Guidelines, 64, 3, (2015)
  34. Penna G.O., Hajjar L.A., Braz T.M., Gonorreia, Rev Soc Bras Med Trop, 33, pp. 451-464, (2000)
  35. Mayor M.T., Roett M.A., Uduhiri K.A., Diagnosis and management of gonococcal infection, Am Fam Physician, 86, pp. 931-938, (2012)
  36. Protocolo clínico E Diretrizes terapêutipara atenção Integral às Pessoas Com infecções Sexualmente transmissíveis, (2015)
  37. Hoffman J., Ali B., Hoffman A., Sheikh I., Gonococcal conjunctivitis: The importance of good-quality conjunctival swabs, Br J Gen Pract, 65, pp. 552-553, (2015)
  38. Pinto N.T., Fagundes L.J., Morais F., Uretrite Gonocócica, Tratado De Dermatologia, (2018)
  39. Tenover F.C., Unger E.R., Nucleic acid probes for detection and identification of infections agents, Diagnostic Molecular Microbiologic: Principles and Applications, pp. 3-25, (1993)
  40. Hook E.W., Ching S.F., Stephens J., Et al., Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs, J Clin Microbiol, 35, pp. 2129-2132, (1997)
  41. Bignell C., Unemo M., 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults, Int J STD AIDS, 24, pp. 85-92, (2013)
  42. Unemo M., Current and future antimicrobial treatment of gonorrhoea—the rapidly evolving Neisseria gonorrhoeae continues to challenge, BMC Infect Dis, 15, (2015)
  43. Bignell C., Fitzgerald M., UK national guideline for the management of gonorrhoea in adults, 2011, Int J STD AIDS, 22, pp. 541-547, (2011)
  44. Workowski K.A., Bolan G.A., Sexually transmitted diseases treatment guidelines, 2015, MMWR Recomm Rep, 64, RR-3, pp. 1-137, (2015)
  45. Canadian guidelines on sexually transmitted infections, Gonococcal Infections Chapter, (2013)
  46. Beber A.C.B., Dallazem L.N.D., Benvegnu A.M., Dermatoviroses, Tratado De Dermatologia, (2018)
  47. Doorbar J., Sterling J.C., The biology of human papillomaviruses, Human Papillomaviruses Clinical and Scientific Advances, pp. 10-23, (2001)
  48. Nicolau S.M., Camargo C.G.C., Diagnóstico do HPV no homem: Peniscopia, citologia, histologia e biologia molecular, Doenças Sexualmente Transmissiveis, (2009)
  49. Vysatova M., Lymphogranuloma venereum, Lek Cesk, 156, pp. 117-118, (2017)
  50. da Costa J.B., Domingues D., Castro R., Et al., Genital ulcers caused by sexually transmitted diseases: Current therapies, diagnosis and their relevance in HIV pandemics, Acta Medica Port, 19, pp. 335-342, (2006)
  51. Ahdoot A., Kotler D.P., Suh J.S., Et al., Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City, J Clin Gastroenterol, 40, pp. 385-390, (2006)
  52. Criado P.R., Belda W., Linfogranuloma Venereo, Tratado De Dermatologia, (2018)
  53. Mabey D., Peeling R.W., Lymphogranuloma venereum, Sex Transm Infect, 78, pp. 90-92, (2002)
  54. Stoner B.P., Cohen S.E., Lymphogranuloma venereum 2015: Clinical presentation, diagnosis, and treatment, Clin Infect Dis, 61, pp. S865-S873, (2015)
  55. McLean C.A., Stoner B.P., Workowski K.A., Treatment of lymphogranuloma venereum, Clin Infect Dis, 44, pp. S147-S152, (2007)
  56. Workowski K.A., Bolan G.A., Sexually transmitted diseases treatment guidelines, 2015, MMWR Recomm Rep, 64, RR-3, pp. 1-137, (2015)
  57. de Vries H.J.C., Morre S.A., White J.A., Moi H., European guideline for the management of lymphogranuloma venereum, 2010, Int J STD AIDS, 21, pp. 533-536, (2010)
  58. Mechai F., de Barbeyrac B., Aoun O., Merens A., Imbert P., Rapp C., Doxycycline failure in lymphogranuloma venereum, Sex Transm Infect, 86, pp. 278-279, (2010)
  59. O'Farrel N., Donovanosis, Sexually Transmitted Infections, pp. 533-540, (2012)
  60. Sethi S., Sarkar R., Garg V., Squamous cell carcinoma complicating donovanosis not a thing of the past, Int J STD AIDS, 25, pp. 894-897, (2014)
  61. O'Farrel N., Hoosen A., Kingston M. 2018 UK national guideline for the management of donovanosis, Int J STD AIDS, 29, pp. 946-948, (2018)
  62. Govender D., Naidoo K., Chetty R., Granuloma inguinale (donovanosis): An unusual cause of otitis media and mastoiditis in children, Am J Clin Pathol, 108, pp. 510-514, (1997)
  63. Scott C.W., Harper D., Jason R.S., Helwig E.B., Neonatal granuloma venereum, Am J Dis Child, 85, pp. 308-315, (1952)
  64. Ramdial P.K., Path F.C., Sing Y., Ramburan A., Naidu T.K., Samuel E.Y., Calonge E., Infantile donovanosis presenting as external auditory canal polyps: A diagnostic trap, Am J Dermatopathol, 34, pp. 818-821, (2012)
  65. Galarza C., Donovanosis, Dermatol Peru, 10, pp. 35-38, (2000)
  66. O'Farrel N., Donovanosis, Sex Transm Infect, 78, pp. 452-457, (2002)
  67. Veeranna S., Raghu T.Y., A clinical and investigational study of donovanosis, Indian J Dermatol Venereol Leprol, 69, pp. 159-162, (2003)
  68. Jardim M.L., Spinelli L.P., Lupi O., Donovanosis (granuloma inguinale, Tropical Dermatology, pp. 325-329, (2016)
  69. O'Farrel N., Moi H., European guideline on donovanosis, Int J STD AIDS, 27, pp. 605-607, (2016)
  70. Caumes E., Janier M., Dupin N., Alcaraz I., Maatouk I., Timsit F., Donovanose (granuloma inguinal), Ann Dermatol Venereol, 133, pp. 251-271, (2006)
  71. O'Farrel N., Donovanosis: An update, Int J STD AIDS, 12, pp. 423-427, (2001)
  72. Wu J.J., Huang D., Pang K.R., Tyring S.K., Selected sexually transmitted diseases and their relationship to HIV, Clin Dermatol, 22, pp. 499-508, (2004)
  73. Sardana K., Garg V.K., Arora P., Khurana N., Malignant transformation of donovanosis (granuloma inguinale) in a HIV-positive patient, Dermatol Online J, 14, (2008)
  74. Carter J.S., Kemp D.J.A., Colorimetric detection system for Calymatobacterium granulomatis, Sex Transm Infect, 76, pp. 134-136, (2000)
  75. Bowden F.J., Mein J., Plunkett C., Bastian I., Pilot study of azithromycin in the treatment of genital donovanosis, Genitourin Med, 72, pp. 17-19, (1994)
  76. Protocolo clínico E Diretrizes terapêutipara atenção Integral às Pessoas Com infecções Sexualmente transmissíveis, (2020)
  77. Maddocks I., Anders E.M., Dennis E., Donovanosis in Papua New Guinea, Br J Vener Dis, 52, pp. 190-196, (1976)
  78. (2016)

Coleções
Livros e Capítulos de Livros - FM/MDT
Livros e Capítulos de Livros - HC/ICHC
Livros e Capítulos de Livros - LIM/50
Livros e Capítulos de Livros - ODS/03
Livros e Capítulos de Livros - ODS/05